MATTIA, Elena
 Distribuzione geografica
Continente #
NA - Nord America 1.444
EU - Europa 572
AS - Asia 134
SA - Sud America 20
AF - Africa 13
Totale 2.183
Nazione #
US - Stati Uniti d'America 1.419
IT - Italia 217
SE - Svezia 105
UA - Ucraina 101
IN - India 79
CN - Cina 39
FI - Finlandia 39
AT - Austria 22
DE - Germania 19
AR - Argentina 18
BG - Bulgaria 17
GB - Regno Unito 15
MX - Messico 14
IE - Irlanda 13
TG - Togo 11
CA - Canada 10
SG - Singapore 7
BE - Belgio 6
CH - Svizzera 5
NL - Olanda 4
IR - Iran 3
LU - Lussemburgo 3
CO - Colombia 2
ES - Italia 2
FR - Francia 2
KR - Corea 2
TR - Turchia 2
AL - Albania 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
ME - Montenegro 1
PA - Panama 1
ZA - Sudafrica 1
Totale 2.183
Città #
Fairfield 222
Chandler 141
Houston 107
Ann Arbor 96
Ashburn 95
Woodbridge 87
Rome 83
Seattle 75
Wilmington 68
Cambridge 58
Princeton 44
Jacksonville 43
Plano 41
San Paolo di Civitate 33
Beijing 27
Lawrence 24
Boston 20
Vienna 19
Federal 18
San Diego 17
Sofia 17
Millbury 16
Andover 13
Dublin 13
Milan 12
Lomé 11
Dearborn 10
Des Moines 7
Norwalk 7
Palermo 7
Boardman 6
Brussels 6
Falls Church 5
Ottawa 5
Bari 4
Bern 4
Puebla City 4
San Mateo 4
Toronto 4
Esch-sur-Alzette 3
Indiana 3
New York 3
Phoenix 3
Prato 3
Auburn Hills 2
Bremen 2
Buffalo 2
Dhanbad 2
Florence 2
Halle 2
Hefei 2
Jinan 2
Konak 2
Leawood 2
Los Angeles 2
Marburg 2
Nanjing 2
Napoli 2
Pasto 2
Pescara 2
Philadelphia 2
Saint Petersburg 2
Segovia 2
Seoul 2
Taranto 2
Tehuacán 2
Ticul 2
Washington 2
Zanjan 2
Arlington Heights 1
Asso 1
Chengdu 1
Crna Gora 1
Delhi 1
Edinburgh 1
Fidenza 1
Freehold 1
Fremont 1
Grafing 1
Hebei 1
Jiaxing 1
La Spezia 1
Las Vegas 1
Latina Scalo 1
Laurel 1
London 1
Massa 1
Moncalieri 1
Montréal 1
Muizenberg 1
Nettuno 1
Nürnberg 1
Osimo 1
Palagonia 1
Panama City 1
Redwood City 1
Reston 1
Rimini 1
Sacramento 1
San Giorgio Del Sannio 1
Totale 1.569
Nome #
Il ciclo litico di EBV e la risposta autofagica in cellule di linfoma di Burkitt 151
Neem oil nanoemulsions: characterisation and antioxidant activity 115
Antisense to Epstein Barr virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes 108
Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication 99
Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia 80
BINDING OF MATRIX ATTACHMENT REGIONS TO LAMIN-B1 72
MULTIPLE POST-TRANSCRIPTIONAL REGULATORY MECHANISMS IN FERRITIN GENE-EXPRESSION 67
Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection 66
Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression 65
Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells 63
Inhibition of Epstein Barr Virus LMP1 gene expression in B lymphocytes by antisense oligonucleotides: Uptake and efficacy of lipid-based and receptor-mediated delivery systems 63
Antimicrobial activity of the essential oil from Satureya montana, L. Lamiaceae 63
Down-regulation of proteolytic complexes following EBV activation in BL cells 63
New drug delivery systems: nanoemulsions and their potential applications 61
Use of antisense oligonucleotides to block LMP1 expression in EBV transformed B-lymphocytes. 60
Inhibition of autophagy in EBV-positive Burkitt’s lymphoma cells enhances EBV lytic genes expression and replication 57
INDUCTION OF NUCLEAR LAMINS A/C DURING INVITRO-INDUCED DIFFERENTIATION OF F9 AND P19 EMBRYONAL CARCINOMA-CELLS 56
THE PIVOTAL ROLE OF FERRITIN IN CELLULAR IRON HOMEOSTASIS 56
Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds 56
Epstein-Barr virus lytic cycle activation alters proteasome subunit expression in Burkitt's lymphoma cells 55
Differentation-specific nuclear matrix proteins cross-linked to DNA by cis-diamminedichloroplatinum. 50
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets 49
Inhibition of in vitro proliferation of Epstein Barr Virus infected B cells by an antisense oligodeoxynucleotide targeted against EBV latent membrane protein LMP1 49
QUANTITATIVE-DETERMINATION OF INTRACELLULAR, FERRITIN-ASSOCIATED RADIOACTIVE IRON BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND IMMUNOPRECIPITATION 43
EBV LYTIC CYCLE ACTIVATION AND PROTECTION FROM APOPTOSIS INDUCING COMPOUNDS 40
ANTIVIRAL EFFECTS OF RESVERATROL ON EPSTEIN BARR VIRUS LATENT AND LYTIC INFECTION 40
HEMIN, CHELATABLE IRON, AND THE REGULATION OF TRANSFERRIN RECEPTOR BIOSYNTHESIS 39
Activation of EBV lytic cycle protects Raji cells from apoptosis and concomitantly increases nuclear matrix protein levels. 37
REGULATION OF INTRACELLULAR IRON DISTRIBUTION IN K562 HUMAN ERYTHROLEUKEMIA-CELLS 36
ROLE OF PROTEIN-SYNTHESIS IN THE ACCUMULATION OF FERRITIN MESSENGER-RNA DURING EXPOSURE OF CELLS TO IRON 36
Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus-Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program 35
ACTIVATION OF EBV LYTIC CYCLE AFFECTS THE ACTIVITY OF CELLULAR PROTEOLITIC SYSTEMS 34
Interaction of EBV latent origin of replication with the nuclear matrix:identificatio of S/MAR sequences and protein components 34
SILENZIAMENTO DELL’ ONCOGENE LMP1 DI EBV : EFFETTI SULLA INFEZIONE LATENTE E LITICA DEL VIRUS 32
La cassetta degli attrezzi per una valutazione dell’apprendimento pertinente ed obiettiva 31
EBV infection protects Burkitt’s lymphoma cells from apoptosis induced by lytic cycle activating compounds. 30
Resveratrol Inhibition of Human Rhinovirus Replication 28
MODULATION OF MAPKS ACTIVITIES BY RESVERATROL IN EPSTEIN BARR VIRUS-POSITIVE BURKITT'S LYMPHOMA CELLS 28
EFFECTS OF RESVERATROL ON THE LATENT AND THE LYTIC PHASES OF EPSTEIN BARR VIRUS INFECTION 25
Inhibition of Epstein Barr Vurus Replication by resveratrol 24
RESVERATROL-INDUCED AUTOPHAGY CONTRIBUTES TO THE INHIBITION OF EPSTEIN BARR VIRUS REPLICATION IN BURKITT’S LYMPHOMA CELLS 17
Totale 2.213
Categoria #
all - tutte 4.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019177 0 0 0 0 0 0 0 0 0 41 81 55
2019/2020444 68 18 12 27 46 50 50 53 39 34 31 16
2020/2021185 21 27 3 14 3 11 9 23 25 30 18 1
2021/2022385 3 29 36 12 46 10 6 43 41 40 40 79
2022/2023489 90 118 49 36 45 55 11 20 27 23 12 3
2023/2024165 29 27 9 12 24 42 1 17 2 2 0 0
Totale 2.213